Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

iGan Partners

Investor type Micro VC
Founders Sam Ifergan

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 39
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 26
Rounds per year 3.55
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 8
Key employees 7
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Software
  • Medical
  • Medical Device
  • Artificial Intelligence
Summary

In 2011 was created iGan Partners, which is appeared as VC. The venture was found in North America in Canada. The leading representative office of defined VC is situated in the Toronto.

This organization was formed by Sam Ifergan. We also calculated 4 valuable employees in our database.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the iGan Partners, startups are often financed by MaRS Investment Accelerator Fund, Right Side Capital Management, LVL1 Group. The meaningful sponsors for the fund in investment in the same round are Rho Canada Ventures, Motorola Solutions Venture Capital, MaRS Investment Accelerator Fund. In the next rounds fund is usually obtained by LVL1 Group, Lumira Ventures, Upfront Ventures.

The average startup value when the investment from iGan Partners is 1-5 millions dollars. Deals in the range of 1 - 5 millions dollars are the general things for fund. The real fund results show that this VC is 22 percentage points more often commits exit comparing to other companies. This iGan Partners works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2018. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are FinTech, Health Care. Among the most popular portfolio startups of the fund, we may highlight Think Research, Flosonics, Rna Diagnostics.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of iGan Partners:
Typical Co-investors
iGan Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after iGan Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Canada
Funds with similar focus located in Canada:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Adverline France, Ile-de-France, Paris
Allianz Private Equity Partners New York, New York, United States
Asia Pacific Ventures California, Redwood City, United States
Asian E-Commerce Alliance Germany, Hamburg
Bridger Management Lee, Massachusetts, United States
Concatenate Capital -
Drecom Japan, Tokyo
Foreign & Commonwealth Office - UK England, London, United Kingdom
GOVTOR China, Jiangsu, Nanjing
Grand Flight Investment China, Shanghai
Harbourton New Jersey, Princeton, United States
Hiro Capital Luxembourg, Luxembourg
LVP Life Science Ventures -
Nestor France, Ile-de-France, Paris
Opportunity Capital Partners Chicago, Illinois, United States
RBC Capital Canada, Ontario, Toronto
U.S. Bancorp Minneapolis, Minnesota, United States
Value4Capital Mazowieckie, Poland, Warsaw
ZenStone Venture Capital California, Santa Clara, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MolecuLight

Hardware
Health Care
11 Aug 2022 Old Toronto, Ontario, Canada

Cosm Medical

Health Care
Medical
Medical Device
$3M04 Apr 2022 Old Toronto, Ontario, Canada

Curv Health

Artificial Intelligence
Fitness
Health Care
Human Resources
Machine Learning
Wellness
$4M01 Mar 2022 Old Toronto, Ontario, Canada

Hyivy Health Inc.

Home Health Care
Medical
Medical Device
mHealth
Personal Health
Rehabilitation
$874K18 Jan 2022 Hamilton, Ontario, Canada

Hyivy Health Inc.

Home Health Care
Medical
Medical Device
mHealth
Personal Health
Rehabilitation
$874K01 May 2021 Hamilton, Ontario, Canada

MedChart

Beauty
Health Care
Information Services
Information Technology
Medical
$17M22 Apr 2021 Toronto, Ontario, Canada

Flosonics

Health Care
Medical
Medical Device
$14M02 Feb 2021 Greater Sudbury, Ontario, Canada

Adracare

Health Care
Software
29 Nov 2019 Canada, Ontario

RetiSpec

Health Care
Medical Device
$250K01 Nov 2019 Canada, Ontario
News
Medchart Raises $17M to Meet Demand for Frictionless Digital Business Practices Across North America

– Medchart announced that it has raised $17M in Seed and Series A funding led by Crosslink Capital and Golden Ventures, with additional funds from Vast Ventures, Union Ventures, iGan Partners, Stanford Law School, and Nas, an original backer.
– The company will apply the current investment to accelerate product innovation and hire new talent to meet the widespread demand for businesses to get patient-authorized health information.
– Medchart squarely addresses one of the slowest, most tedious, and fractured processes: getting patient health records for common business tasks.
– Medchart lets businesses easily, securely, and cost-effectively access and exchange patient-authorized digital health information for everything from life sciences real-world evidence or insurance underwriting to legal claims.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent iGan Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: